Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis–experience of a referral centre in Germany
Open Access
- 25 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (4) , 1021-1030
Abstract
Chronic peritoneal dialysis (PD) can be complicated by encapsulating peritoneal sclerosis (EPS), the most severe complication associated with long-term PD. In this study, we retrospectively analysed 49 EPS patients regarding clinical presentation, histopathological findings, treatment and long-term clinical outcome at our referral centre. Patients were divided into two clinical categories: severe and mild/moderate. All patients in the severe group and most patients in the mild/moderate group had symptoms consistent with EPS. The most common computed tomographic findings were peritoneal thickening in both groups. Small bowel dilatation was frequently present in the severe group. The time of onset of symptoms consistent with EPS to the surgical procedure was median 5 months with an inter-quartile range of 2–12 months in the severe group. To date, 25 of 31 patients in the severe group (follow-up 45.6 ± 39.0 months after surgery) are alive. In the mild/moderate group, 8 of 11 patients are alive (follow-up 41.6 ± 21.6 months). The histological features were consistent with EPS in all biopsies. The outcome of patients even with severe EPS is not worse. It is a precondition that these patients are treated in specialized referral centres. The time of first clinical symptoms consistent with EPS to requirement of surgery is very short. Earlier diagnosis of the disease is mandatory, even in asymptomatic patients.Keywords
This publication has 46 references indexed in Scilit:
- Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in CanadaNephrology Dialysis Transplantation, 2012
- Difference in the Expression of Hormone Receptors and Fibrotic Markers in the Human Peritoneum—Implications for Therapeutic Targets to Prevent Encapsulating Peritoneal SclerosisPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2011
- A Collaborative Approach to Understanding EPS: The European PerspectivePeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2011
- Encapsulating Peritoneal Sclerosis in the New MillenniumClinical Journal of the American Society of Nephrology, 2009
- Assessing the Validity of an Abdominal CT Scoring System in the Diagnosis of Encapsulating Peritoneal SclerosisClinical Journal of the American Society of Nephrology, 2008
- Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transportKidney International, 2008
- Comparison Between the Pathology of Encapsulating Sclerosis and Simple Sclerosis of the Peritoneal Membrane in Chronic Peritoneal DialysisTherapeutic Apheresis and Dialysis, 2008
- Encapsulating peritoneal sclerosis in Japan: A prospective, controlled, multicenter studyAmerican Journal of Kidney Diseases, 2004
- The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expressionNature Cell Biology, 2000
- CorrespondenceAmerican Journal of Kidney Diseases, 1996